APA (7th ed.) Citation

Chistiakov, D. A., Chekhonin, I. V., & Chekhonin, V. P. (2017). The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme. European journal of pharmacology, 810, 70-82. https://doi.org/10.1016/j.ejphar.2017.05.064

Chicago Style (17th ed.) Citation

Chistiakov, Dimitry A., Ivan V. Chekhonin, and Vladimir P. Chekhonin. "The EGFR Variant III Mutant as a Target for Immunotherapy of Glioblastoma Multiforme." European Journal of Pharmacology 810 (2017): 70-82. https://doi.org/10.1016/j.ejphar.2017.05.064.

MLA (9th ed.) Citation

Chistiakov, Dimitry A., et al. "The EGFR Variant III Mutant as a Target for Immunotherapy of Glioblastoma Multiforme." European Journal of Pharmacology, vol. 810, 2017, pp. 70-82, https://doi.org/10.1016/j.ejphar.2017.05.064.